Rafael Tourinho‐Barbosa
Papers
5
Total Citations
208
H-Index
5
About
Rafael Tourinho‐Barbosa is a leading urologic surgeon and researcher whose work centers on the intersection of focal therapy, robotic surgery, and prostate cancer management. His major contributions lie in refining salvage treatments after focal therapy failure, demonstrating that robot-assisted radical prostatectomy (RARP) remains a viable option with acceptable oncological and functional outcomes—a critical insight for patients who have undergone less invasive initial treatments. His 2019 study on salvage RARP after focal therapy (78 citations) and his 2017 analysis of prior focal therapy’s impact (52 citations) are foundational in this niche, guiding clinical decision-making for recurrent disease. Tourinho‐Barbosa has also advanced diagnostic accuracy, comparing micro-ultrasound biopsies to MRI fusion techniques (52 citations), and has explored high-risk prostate cancer management with RARP (17 citations). Notably, his recent randomized trial (2023) on pelvic floor muscle training and duloxetine for post-RARP urinary incontinence addresses a key quality-of-life concern, showing his commitment to holistic patient outcomes. With over 200 cumulative citations, his work bridges surgical innovation and evidence-based rehabilitation, making him a pivotal figure in modern urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5